Lauren A. Gamble

473 total citations
23 papers, 227 citations indexed

About

Lauren A. Gamble is a scholar working on Surgery, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Lauren A. Gamble has authored 23 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 11 papers in Pathology and Forensic Medicine and 8 papers in Molecular Biology. Recurrent topics in Lauren A. Gamble's work include Genetic factors in colorectal cancer (10 papers), Cancer-related gene regulation (6 papers) and Gastric Cancer Management and Outcomes (6 papers). Lauren A. Gamble is often cited by papers focused on Genetic factors in colorectal cancer (10 papers), Cancer-related gene regulation (6 papers) and Gastric Cancer Management and Outcomes (6 papers). Lauren A. Gamble collaborates with scholars based in United States, Malaysia and Australia. Lauren A. Gamble's co-authors include Jeremy L. Davis, Theo Heller, Jonathan M. Hernandez, Andrew M. Blakely, Grace‐Ann Fasaye, Martha Quezado, Christopher Koh, Markku Miettinen, Shreya Gupta and Samantha M. Ruff and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Lauren A. Gamble

22 papers receiving 226 citations

Peers

Countries citing papers authored by Lauren A. Gamble

Since Specialization

Citations

This map shows the geographic impact of Lauren A. Gamble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren A. Gamble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren A. Gamble more than expected).

Fields of papers citing papers by Lauren A. Gamble

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren A. Gamble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren A. Gamble. The network helps show where Lauren A. Gamble may publish in the future.

Co-authorship network of co-authors of Lauren A. Gamble

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren A. Gamble. A scholar is included among the top collaborators of Lauren A. Gamble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren A. Gamble. Lauren A. Gamble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lessons learned from 150 total gastrectomies for prevention of cancer 2024 ·Journal of Gastrointestinal Surgery ·(unknown), (unknown), (unknown), Lauren A. Gamble, (unknown), (unknown), David Snyder, Grace‐Ann Fasaye, (unknown), (unknown), Ning Miao, Markku Miettinen, Martha Quezado, Sun A. Kim, Louis Y. Korman, Theo Heller, Andrew M. Blakely, Jonathan M. Hernandez, Jeremy L. Davis	3
2	Germline CDH1 Variants and Lifetime Cancer Risk 2024 ·JAMA ·(unknown), Grace‐Ann Fasaye, (unknown), Lauren A. Gamble, (unknown), (unknown), (unknown), Andrew M. Blakely, (unknown), Kerry Kingham, (unknown), Linda Rodgers, (unknown), Sonia S. Kupfer, James M. Ford, Daniel C. Chung, James G. Dowty, Joshua N. Sampson, Jeremy L. Davis	14
3	Early Immune Changes Support Signet Ring Cell Dormancy in CDH1 -Driven Hereditary Diffuse Gastric Carcinogenesis 2023 ·Molecular Cancer Research ·Benjamin L. Green, Lauren A. Gamble, Laurence P. Diggs, Darryl Nousome, Jesse C. Patterson, Brian A. Joughin, Billel Gasmi, (unknown), (unknown), Markku Miettinen, Martha Quezado, Jonathan M. Hernandez, Michael B. Yaffe, Jeremy L. Davis	4
4	Micronutrient Supplementation and Bone Health After Prophylactic Total Gastrectomy in Patients With CDH1 Variants 2023 ·The Journal of Clinical Endocrinology & Metabolism ·Lauren A. Gamble, (unknown), (unknown), (unknown), (unknown), (unknown), Andrew M. Blakely, Smita Jha, Mark A. Ahlman, Jeremy L. Davis	7
5	Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics 2023 ·npj Breast Cancer ·Lauren A. Gamble, (unknown), (unknown), (unknown), Paul Juneau, (unknown), Andrew M. Blakely, Bernadette Redd, Jeremy L. Davis	4
6	Protocol for isolation of signet ring cells from human gastric mucosa 2023 ·STAR Protocols ·(unknown), Lauren A. Gamble, (unknown), Benjamin L. Green, (unknown), (unknown), (unknown), Jonathan M. Hernandez, Jeremy L. Davis	0
7	Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study 2023 ·The Lancet Oncology ·(unknown), (unknown), Lauren A. Gamble, (unknown), (unknown), Grace‐Ann Fasaye, Martha Quezado, Markku Miettinen, Louis Y. Korman, Christopher Koh, Theo Heller, Jeremy L. Davis	24
8	Costs of Cancer Prevention: Physical and Psychosocial Sequelae of Risk-Reducing Total Gastrectomy 2023 ·Journal of Clinical Oncology ·(unknown), Lauren A. Gamble, (unknown), (unknown), (unknown), (unknown), Grace‐Ann Fasaye, (unknown), Maureen Connolly, (unknown), Ann Berger, Theo Heller, Andrew M. Blakely, Jonathan M. Hernandez, Jeremy L. Davis	8
9	Association of CDH1 Germline Variants and Colon Polyp Phenotypes in Patients With Hereditary Diffuse Gastric Cancer 2022 ·SHILAP Revista de lepidopterología ·(unknown), Lauren A. Gamble, (unknown), (unknown), (unknown), Grace‐Ann Fasaye, (unknown), Sandeep Gurram, Martha Quezado, Markku Miettinen, Christopher Koh, Theo Heller, Jeremy L. Davis	2
10	Cytoreduction and HIPEC for Gastric Carcinomatosis: Multi-institutional Analysis of Two Phase II Clinical Trials 2022 ·Annals of Surgical Oncology ·Benjamin L. Green, (unknown), Lauren A. Gamble, (unknown), (unknown), Maureen Connolly, Monica Epstein, Jonathan M. Hernandez, Andrew M. Blakely, Brian D. Badgwell, Jeremy L. Davis	18
11	Frequent cleft lip and palate in families with pathogenic germline CDH1 variants 2022 ·Frontiers in Genetics ·Benjamin L. Green, Grace‐Ann Fasaye, (unknown), (unknown), Lauren A. Gamble, Jeremy L. Davis	1
12	ASO Visual Abstract: Cytoreduction and HIPEC for Gastric Carcinomatosis: Multi-institutional Analysis of Two Phase II Clinical Trials 2022 ·Annals of Surgical Oncology ·Benjamin L. Green, (unknown), Lauren A. Gamble, (unknown), Kristen Robinson, Maureen Connolly, Monica Epstein, Jonathan M. Hernandez, Andrew M. Blakely, Brian D. Badgwell, Jeremy L. Davis	1
13	Decision-making and regret in patients with germline CDH1 variants undergoing prophylactic total gastrectomy 2022 ·Journal of Medical Genetics ·Lauren A. Gamble, (unknown), (unknown), Grace‐Ann Fasaye, Christopher Koh, Louis Y. Korman, (unknown), Theo Heller, Jonathan M. Hernandez, Andrew M. Blakely, Jeremy L. Davis	8
14	Surveillance and Surgical Considerations in Hereditary Diffuse Gastric Cancer 2021 ·Gastrointestinal Endoscopy Clinics of North America ·Lauren A. Gamble, Jeremy L. Davis	3
15	Evaluation of confocal laser endomicroscopy for detection of occult gastric carcinoma in CDH1 variant carriers 2021 ·Journal of Gastrointestinal Oncology ·(unknown), Lauren A. Gamble, (unknown), Samantha M. Ruff, Maureen Connolly, (unknown), Martha Quezado, Markku Miettinen, (unknown), Andrew M. Blakely, Jonathan M. Hernandez, Theo Heller, Christopher Koh, Jeremy L. Davis	10
16	Enhanced endoscopic detection of occult gastric cancer in carriers of pathogenic CDH1 variants 2020 ·Journal of Gastroenterology ·(unknown), Lauren A. Gamble, (unknown), Samantha M. Ruff, Martha Quezado, Markku Miettinen, Grace‐Ann Fasaye, (unknown), Jonathan M. Hernandez, Theo Heller, Christopher Koh, Jeremy L. Davis	22
17	Targeting CA 19-9 with a humanized monoclonal antibody at the time of surgery may decrease recurrence rates for patients undergoing resections for pancreatic cancer, cholangiocarcinoma and metastatic colorectal cancer 2020 ·Journal of Gastrointestinal Oncology ·Shreya Gupta, (unknown), Reed I. Ayabe, Tahsin M. Khan, Lauren A. Gamble, Surajit Sinha, (unknown), Andrew M. Blakely, Jeremy L. Davis, Jonathan M. Hernandez	13
18	Elevated Serum α-Fetoprotein is Associated with Abbreviated Survival for Patients with Fibrolamellar Hepatocellular Carcinoma Who Undergo a Curative Resection 2020 ·Annals of Surgical Oncology ·(unknown), Shreya Gupta, Mackenzie L. Shindorf, Lauren A. Gamble, Samantha M. Ruff, Justin A. Drake, Theo Heller, Jim Y. Wan, Paxton V. Dickson, Evan S. Glazer, Jeremy L. Davis, Jeremiah L. Deneve, Jonathan M. Hernandez	14
19	Staging Laparoscopy is Underutilized in the Management of Gastric Adenocarcinoma 2019 ·Annals of Surgical Oncology ·Eric Groh, Shreya Gupta, Zachary J. Brown, Lindsey Enewold, Lauren A. Gamble, Jonathan M. Hernandez, Jeremy L. Davis	14
20	Chronically Retained Fecalith following Laparoscopic Appendectomy 2016 ·Lauren A. Gamble, Andrew Saxe	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact